Prostate cancer remains one of the most common cancers among men, affecting approximately 1 in 8. Early detection and appropriate treatment are crucial for better outcomes. While the PSA blood test has long been the standard for screening, a newer imaging technique called PSMA PET scan is emerging as a vital tool for determining the extent of the disease and guiding treatment decisions.
Dr. Phillip Koo, Executive Vice President and Chief Medical Officer at the Prostate Cancer Foundation, explains that PSMA (prostate-specific membrane antigen) is a biomarker found on the surface of prostate cancer cells. A PSMA PET scan uses a radioactive tracer to bind to this antigen, allowing doctors to see if cancer has spread beyond the prostate. "PSMA is so important with regards to detecting disease and also determining the appropriate treatments that patients should receive down the road," says Dr. Koo. He notes that over 80-90% of prostate cancer patients express this biomarker, making the test widely applicable.
Bill, a prostate cancer survivor and patient advocate, shares his personal experience. Diagnosed 18 years ago, Bill took an active role in his care by researching his condition. He discovered PSMA testing and brought it to his doctor's attention. "I came across this listing about PSMA, and I took that to my doctor, and we decided that that would be a great course of action in our attack plan to this disease," Bill recalls. After undergoing the PSMA scan, he felt empowered because it provided clarity about his disease status. "It helped me understand truly where I am in this journey," he says.
The results of the PSMA scan enabled Bill and his oncologist to craft a personalized treatment plan. "We examined all the results and crafted a plan of action," he says. "I've never been a passive participant in this process; I always take an active role because information is power."
Dr. Koo emphasizes the importance of patient-doctor communication. "Patients need to speak up, and they also need to be heard," he says. To achieve this, patients should educate themselves about PSMA testing. "Knowing your PSMA status is vitally important to your cancer care," he adds.
The PSMA PET scan is not just for initial staging; it also plays a role in guiding treatment for men with recurrent or advanced disease. By identifying where cancer has spread, doctors can choose more targeted therapies, such as PSMA-targeted radioligand therapy, which delivers radiation directly to cancer cells.
For men diagnosed with prostate cancer, asking about PSMA testing could be a game-changer. As Bill's experience shows, being proactive and informed can lead to better outcomes. Dr. Koo encourages patients to visit GetYourScan.com to learn more about the PSMA scan and how to advocate for it in their care.
In summary, PSMA PET imaging is a powerful tool that provides critical information for managing prostate cancer. Men diagnosed with prostate cancer should discuss with their doctors whether PSMA testing is appropriate for them.
